Original article<br>Neuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture

Khaled Radad; Dieter Scheller; Wolf-Dieter Rausch; Heinz Reichmann; Gabrielle Gille

doi:10.5114/fn.2014.43789

eISSN: 1509-572x
ISSN: 1641-4640

Folia Neuropathologica

Current issue Archive Manuscripts accepted About the journal Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Ethical standards and procedures

Editorial System

Submit your Manuscript

Editorial Policies

Sarajevo Declaration on Integrity and Visibility of Scholarly Publications

2/2014
vol. 52

Send email

Copy url:

abstract:

Original article
Neuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture

Khaled Radad

,

Dieter Scheller

,

Wolf-Dieter Rausch

,

Heinz Reichmann

,

Gabrielle Gille

Folia Neuropathol 2014; 52 (2): 179-186

DOI: https://doi.org/10.5114/fn.2014.43789

Online publish date: 2014/06/30

View full text Get citation

PlumX metrics:

Introduction: Dopamine agonists are suggested to be more efficacious in treating Parkinson’s disease (PD) as they have neuroprotective properties in addition to their receptor-related actions.

Aim of the study: The present study was designed to investigate the neuroprotective effects of rotigotine, a D3/D2/D1 dopamine receptor agonist, against the two powerful complex I inhibitors, 1-methyl-4-phenylpyridinium (MPP⁺) and rotenone, in primary mesencephalic cell culture relevant to PD.

Material and methods: Primary mesencephalic cell cultures were prepared from embryonic mouse mesencephala at gestation day 14. Three sets of cultures were treated with rotigotine alone, rotigotine and MPP⁺, and rotigotine and rotenone to investigate the effect of rotigotine on the survival of dopaminergic neurons against age-, MPP⁺- and rotenone-induced cell death. At the end of each treatment, cultures were fixed and stained immunohistochemically against tyrosine hydroxylase (TH). The effect of rotigotine against rotenone-induced reactive oxygen species (ROS) production was measured using CH-H2DCFDA fluorescence dye.

Results: Rotigotine alone did not influence the survival of tyrosine hydroxylase immunoreactive (THir) neurons except at 10 µM, it significantly decreased the number of THir neurons by 40% compared to untreated controls. Treatment of cultures with 0.01 µM rotigotine rescued 10% of THir neurons against MPP⁺-induced cell death. Rotigotine was also found to significantly rescue 20% of THir neurons at 0.01 µM of rotenone-treated cultures. Using of CH-H2DCFDA fluorescence dye, it was found that rotigotine significantly attenuated ROS production compared to rotenone-treated cultures.

Conclusions: Rotigotine provides minor protection against MPP⁺ and rescues a significant number of THir neurons against rotenone in primary mesencephalic cell cultures relevant to PD.

keywords:

Original articleNeuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture

Khaled Radad , Dieter Scheller , Wolf-Dieter Rausch , Heinz Reichmann , Gabrielle Gille

dopamine agonists, dopaminergic neurons, MPP+, neuroprotection, Parkinson’s disease, rotenone, rotigotine

Original article
Neuroprotective effect of rotigotine against complex I inhibitors, MPP+ and rotenone, in primary mesencephalic cell culture

Khaled Radad

,

Dieter Scheller

,

Wolf-Dieter Rausch

,

Heinz Reichmann

,

Gabrielle Gille

dopamine agonists, dopaminergic neurons, MPP⁺, neuroprotection, Parkinson’s disease, rotenone, rotigotine